Page last updated: 2024-08-21

methoxyhydroxyphenylglycol and Hypertrophy, Left Ventricular

methoxyhydroxyphenylglycol has been researched along with Hypertrophy, Left Ventricular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davidson, PM; Dennison-Himmelfarb, C1
Akutsu, M; Jin, EZ; Kakinoki, S; Katoh, K; Kitabatake, A; Nomura, A; Shimono, H; Takechi, S1

Other Studies

2 other study(ies) available for methoxyhydroxyphenylglycol and Hypertrophy, Left Ventricular

ArticleYear
Population health studies - what do they tell us?
    Heart, lung & circulation, 2013, Volume: 22, Issue:11

    Topics: Black People; Blood Pressure; Carotid Intima-Media Thickness; Humans; Hypertrophy, Left Ventricular; Male; Methoxyhydroxyphenylglycol; Urban Population; White People

2013
Recovery of cardiac norepinephrine concentration and tyrosine hydroxylase activity by the central alpha2-adrenoceptor agonist guanabenz in rats with aortic constriction.
    Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:3

    Topics: Adrenal Glands; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Body Weight; Constriction; Guanabenz; Heart; Heart Ventricles; Hypertrophy, Left Ventricular; Kidney; Liver; Male; Methoxyhydroxyphenylglycol; Myocardium; Norepinephrine; Organ Size; Rats; Rats, Wistar; Spleen; Tyrosine 3-Monooxygenase; Vas Deferens

1999